TMO Stock Overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Thermo Fisher Scientific Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$434.11 |
| 52 Week High | US$609.85 |
| 52 Week Low | US$415.60 |
| Beta | 0.79 |
| 1 Month Change | -14.24% |
| 3 Month Change | -20.47% |
| 1 Year Change | -15.54% |
| 3 Year Change | -9.66% |
| 5 Year Change | 83.54% |
| Change since IPO | 4,684.07% |
Recent News & Updates
Recent updates
Thermo Fisher: An Up To 35% Undervalued Healthcare Gem I Like On Weakness
Sep 28Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Sep 10
Thermo Fisher Scientific: A High-Quality Investment For Double-Digit Returns
Aug 28Thermo Fisher: Cash Flow Returns On Investments Analysis
Aug 14Calculating The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 25Thermo Fisher Scientific: Continuing To Add To The Fortress
Jul 09Thermo Fisher: A Master Compounder In Healthcare
Jul 03These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Jun 07Buy Thermo Fisher, But With Caution
Jun 01Thermo Fisher Scientific Inc.'s (NYSE:TMO) Intrinsic Value Is Potentially 25% Below Its Share Price
Apr 26We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Feb 26Thermo Fisher Scientific: Is This Quality Stock A Buy?
Feb 22Thermo Fisher Scientific Q4 2022 Earnings Preview
Jan 31Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Jan 17Thermo Fisher Scientific: Growing Diagnosis Market May Provide Upside
Jan 12Thermo Fisher Scientific prices $1.2B note offering
Nov 15Thermo Fisher Scientific: On The Road To Discovery
Nov 07Thermo Fisher Scientific Q3 2022 Earnings Preview
Oct 25We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Oct 25Thermo Fisher Scientific prices ¥109.5B senior notes offering
Oct 14What Does Thermo Fisher Scientific Inc.'s (NYSE:TMO) Share Price Indicate?
Sep 28Shareholder Returns
| TMO | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | -6.0% | -6.9% | -2.4% |
| 1Y | -15.5% | -18.6% | 4.1% |
Return vs Industry: TMO exceeded the US Life Sciences industry which returned -18.6% over the past year.
Return vs Market: TMO underperformed the US Market which returned 4.1% over the past year.
Price Volatility
| TMO volatility | |
|---|---|
| TMO Average Weekly Movement | 3.0% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in US Market | 14.2% |
| 10% least volatile stocks in US Market | 2.7% |
Stable Share Price: TMO is less volatile than 75% of US stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: TMO's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 130,000 | Marc Casper | https://www.thermofisher.com |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories.
Thermo Fisher Scientific Inc. Fundamentals Summary
| TMO fundamental statistics | |
|---|---|
| Market Cap | US$169.82b |
| Earnings (TTM) | US$5.94b |
| Revenue (TTM) | US$43.42b |
28.6x
P/E Ratio3.9x
P/S RatioIs TMO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMO income statement (TTM) | |
|---|---|
| Revenue | US$43.42b |
| Cost of Revenue | US$26.12b |
| Gross Profit | US$17.30b |
| Other Expenses | US$11.36b |
| Earnings | US$5.94b |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 15.19 |
| Gross Margin | 39.84% |
| Net Profit Margin | 13.68% |
| Debt/Equity Ratio | 77.6% |
How did TMO perform over the long term?
See historical performance and comparison